B
Blair Seifert
Researcher at University of Saskatchewan
Publications - 5
Citations - 73
Blair Seifert is an academic researcher from University of Saskatchewan. The author has contributed to research in topics: Cannabis & Cannabidiol. The author has an hindex of 3, co-authored 4 publications receiving 53 citations. Previous affiliations of Blair Seifert include Royal University Hospital & Saskatchewan Health.
Papers
More filters
Journal ArticleDOI
Dosage Related Efficacy and Tolerability of Cannabidiol in Children With Treatment-Resistant Epileptic Encephalopathy: Preliminary Results of the CARE-E Study.
Richard J. Huntsman,Richard Tang-Wai,Richard Tang-Wai,Jane Alcorn,Stephanie Vuong,Bryan V. Acton,Scott Corley,Robert B. Laprairie,Andrew W. Lyon,Andrew W. Lyon,Simona Meier,Darrell D. Mousseau,Doris Newmeyer,Erin J. Prosser-Loose,Blair Seifert,Blair Seifert,Jose F. Tellez-Zenteno,Linda Huh,Edward Leung,Philippe Major +19 more
TL;DR: The preliminary data suggest an initial CBD target dose of 5–6 mg/kg/day when a 1:20 THC:CBD CHE is used, and the reduction in seizure frequency seen suggests improved seizure control when a whole plant CHe is used.
Journal ArticleDOI
The protocol for the Cannabidiol in children with refractory epileptic encephalopathy (CARE-E) study: a phase 1 dosage escalation study.
Darren Reithmeier,Richard Tang-Wai,Richard Tang-Wai,Richard Tang-Wai,Blair Seifert,Blair Seifert,Andrew W. Lyon,Andrew W. Lyon,Jane Alcorn,Bryan V. Acton,Bryan V. Acton,Scott Corley,Erin J. Prosser-Loose,Darrell D. Mousseau,Hyun J. Lim,Jose F. Tellez-Zenteno,Linda Huh,Edward Leung,Lionel Carmant,Richard J. Huntsman,Richard J. Huntsman +20 more
TL;DR: This study will provide the first high quality analysis of safety of CBD-enriched Cannabis herbal extract in pediatric patients in relation to dosage and pharmacokinetics of the active cannabinoids.
Journal ArticleDOI
Cannabis for the treatment of paediatric epilepsy? An update for Canadian paediatricians.
Richard J. Huntsman,Richard Tang-Wai,Richard Tang-Wai,Bryan V. Acton,Jane Alcorn,Andrew W. Lyon,Andrew W. Lyon,Darrell D. Mousseau,Blair Seifert,Blair Seifert,Robert B. Laprairie,Erin J. Prosser-Loose,Lumir Ondrej Hanus +12 more
TL;DR: The general paediatrician is provided with a brief review of cannabinoid biology, the literature regarding their use in children with drug resistant epilepsy, the current Health Canada and Canadian Paediatric Society recommendations and also the regulations from the physician regulatory bodies for each province and territory.
Book ChapterDOI
Pediatric Dosing Considerations for Medical Cannabis
TL;DR: The chapter that follows emphasizes the impact of agerelated changes in PK and PD processes as important considerations in pediatric dosing recommendations for medical Cannabis.
Journal ArticleDOI
Removing barriers to accessing medical cannabis for paediatric patients
Richard J. Huntsman,Evan Lewis,Charlotte Moore-Hepburn,Jane Alcorn,Holly Mansell,Juan Pablo Appendino,Richard E. Bélanger,Scott Corley,Bruce Crooks,Y. Finkelstein,Allen Finley,Ryan Fung,Andrea Gilpin,Catherine Litalien,Tim F. Oberlander,Jacob A. Palm,Declan Quinn,S. Rassekh,Alexander E. Repetski,Michael J. Rieder,Blair Seifert,Alan G. Shackelford,Hal Siden,Michael Szafron,Geert W. ‘t Jong,Régis Vaillancourt,Lauren E. Kelly +26 more
TL;DR: In this article , the authors explore several of these barriers and provide recommendations to decision-makers to enable a family-centered and evidence-based approach to medical cannabis medicine and research for children.